Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Eduardo Sotomayor

Studies on the Etiopathogenesis of T-Cell Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Fabiola Valvert Gamboa

Oncology Institute of Guatemala: experience with NK/T-cell Lymphomas

Non-Hodgkin lymphoma

Pathology

Hugh-George G Patterton

Reprogramming of the Trypanosoma brucei epigenome during human infection

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Dirk P Dittmer

Regulation of the KSHV Latent Promoter

Non-Hodgkin lymphoma Kaposi sarcoma

Andrew M Evens

MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm

Non-Hodgkin lymphoma

Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology